Page 9 - Tissue Engineering News Today

The London Biotechnology Show aims to foster collaboration, innovation, and progress in the field of biotechnology.

Artificial cells, made with the use of synthetic materials, have been produced in international research led at the University of Strathclyde.

Jean C. Pfau is an immunotoxicologist serving as a scientific consultant for the Center for Asbestos Related Disease (CARD) in Libby, Montana

Swiss government and European Union award 11.8 million CHF for next generation clinical trials of novel arthritis repair. The researchers at the Department of Biomedicine, University of Basel and University Hospital Basel, are actively recruiting for clinical trials.

In recent decades, microphysiological constructs and systems (MPCs and MPSs) have undergone significant development, ranging from self-organized organoids to high-throughput organ-on-a-chip platforms. Advances in biomaterials, bioinks, 3D bioprinting, micro/nanofabrication, and sensor technologies have contributed to diverse and innovative biofabrication tactics. MPCs and MPSs, particularly tissue chips relevant to absorption, distribution, metabolism, excretion, and toxicity, have demonstrated ...

EXCLUSIVE: MailOnline goes behind the scenes at the UKs very own Frankenstein lab where scientists are working on ways to 3D print organs from scratch in the hope of revolutionizing medicine.

The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans.

<p>The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans. The procedure called Nasal Chondrocyte Tissue-Engineered Cartilage, or N-TEC, provides an innovative alternative to cure confined knee cartilage lesions as well as to address degenerative OA cases that have to date required knee joint replacements – prosthetics that routinely need repl...

The global regenerative medicine market is experiencing significant growth, attributable to the high adoption of stem cell technology, the increase in the usage of nanotechnology, the rise in chronic diseases and trauma emergencies, and recent developments in the field of medical equipment technology.Wilmington, Delaware, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Regenerative Medicine Market by Product Type (Gene Therapy, Cell Therapy, ...

Medical-grade Polylactide (PLA) Market Analysis and Future Prospects for 2030